Pembrolizumab in relapsed or refractory Richter syndrome

Affiliations

• ¹ Dana-Farber Cancer Institute, Boston, MA, USA.
• ² Universitäts-klinikum des Saarlandes Innere Medizin I, Homburg, Germany.
• ³ Experimental and Clinical Oncology, Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
• ⁴ City of Hope, Duarte, CA, USA.
• ⁵ University of Cologne, Cologne, Germany.
• ⁶ Anadolu Medical Center, Istanbul, Turkey.
• ⁷ Olivia Newton-John Cancer Research Institute, Austin Health, Victoria, Australia.
• ⁸ Swedish Center for Blood Disorders and Stem Cell Transplants, Swedish Cancer Institute, Seattle, WA, USA.
• ⁹ Rogel Cancer Center, Ann Arbor, MI, USA.
• ¹⁰ Institut Gustave Roussy, Villejuif, France.
• ¹¹ Perelman Center for Advanced Medicine, University of Pennsylvania, Philadelphia, PA, USA.
• ¹² Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.
• ¹³ Merck & Co., Inc, Kenilworth, NJ, USA.
• ¹⁴ The James Cancer Hospital and Solove Research Institute, Ohio State University, Columbus, OH, USA.